原发性乳腺癌中的雌激素和孕激素受体与无病生存期
Oestrogen and progesterone receptors and disease-free interval in primary breast cancer.
作者信息
Alanko A, Heinonen E, Scheinin T M, Tolppanen E M, Vihko R
出版信息
Br J Cancer. 1984 Nov;50(5):667-72. doi: 10.1038/bjc.1984.234.
Abstract
Oestrogen and progesterone receptor assays were performed in 286 women with primary breast cancer, and the patient group was followed up for a minimum of 24 months. Of the 263 patients belonging to clinical stages I-III and serving as the population used for calculation of disease-free interval only 1.9% received postoperative endocrine treatment and 6.5% chemotherapy. No significant relationship between the presence or concentrations of oestrogen or progesterone receptor and the disease-free interval was observed. It is therefore possible that the positive relationship between these variables reported in some investigations reflects an influence by adjuvant endocrine measures.
摘要
对286例原发性乳腺癌女性患者进行了雌激素和孕激素受体检测，并对患者组进行了至少24个月的随访。在属于临床I - III期且用作无病生存期计算人群的263例患者中，仅1.9%接受了术后内分泌治疗，6.5%接受了化疗。未观察到雌激素或孕激素受体的存在或浓度与无病生存期之间存在显著关系。因此，一些研究报告的这些变量之间的正相关关系可能反映了辅助内分泌措施的影响。
相似文献
1
Oestrogen and progesterone receptors and disease-free interval in primary breast cancer.
Br J Cancer. 1984 Nov;50(5):667-72. doi: 10.1038/bjc.1984.234.
2
[Significance of hormone receptors of breast cancer cells for the duration of a disease-free interval].
Wien Klin Wochenschr. 1985 May 24;97(11):493-7.
3
The effect of oestrogen and progesterone receptors on recurrence and survival in patients with carcinoma of the breast.
Br J Cancer. 1985 Feb;51(2):263-70. doi: 10.1038/bjc.1985.38.
4
Estrogen and progesterone receptors as prognostic factors in early breast cancer.
Recent Results Cancer Res. 1984;91:192-8. doi: 10.1007/978-3-642-82188-2_27.
5
Progesterone and oestrogen receptors in human breast cancer.
Aust N Z J Med. 1978 Dec;8(6):630-8. doi: 10.1111/j.1445-5994.1978.tb04853.x.
6
[Steroid hormone receptors and survival in breast cancer patients].
Vopr Onkol. 1986;32(6):71-6.
7
Significance of estrogen and progesterone receptors, disease-free interval, and site of first metastasis on survival of breast cancer patients.
Cancer. 1985 Oct 1;56(7):1696-700. doi: 10.1002/1097-0142(19851001)56:7<1696::aid-cncr2820560738>3.0.co;2-n.
8
Prognostic significance of oestrogen and progestogen receptor activities in breast cancer.
Br J Surg. 1987 Nov;74(11):1009-13. doi: 10.1002/bjs.1800741118.
9
Estrogen receptor protein in breast cancer as a predictor of recurrence.
Cancer. 1981 May 15;47(10):2364-7. doi: 10.1002/1097-0142(19810515)47:10<2364::aid-cncr2820471007>3.0.co;2-s.
10
Relationship of estrogen and progesterone receptors to prognosis in breast cancer.
Ann Surg. 1988 Jan;207(1):75-9. doi: 10.1097/00000658-198801000-00015.
引用本文的文献
1
A prospective analysis of immunohistochemically determined hormone receptors and nuclear features as predictors of early recurrence in primary breast cancer.
Breast Cancer Res Treat. 1995;36(1):11-21. doi: 10.1007/BF00690180.
2
Disease-free interval and estrogen receptor activity in tumor tissue of patients with primary breast cancer: analysis after long-term follow-up.
Breast Cancer Res Treat. 1985;6(2):123-30. doi: 10.1007/BF02235743.
3
Oestrogen receptors in primary breast cancer.
Br J Cancer. 1985 Jun;51(6):907-9. doi: 10.1038/bjc.1985.138.
4
Oestrogen receptors in primary and advanced breast cancer: an eight year review of 704 cases.
Br J Cancer. 1987 Jan;55(1):67-73. doi: 10.1038/bjc.1987.14.
5
Prognostic implication of labeling index versus estrogen receptors and tumor size in node-negative breast cancer.
Breast Cancer Res Treat. 1986;7(3):161-9. doi: 10.1007/BF01806246.
6
Progesterone receptor activity and relapse-free survival in patients with primary breast cancer: the role of adjuvant chemotherapy.
Breast Cancer Res Treat. 1987;9(3):191-9. doi: 10.1007/BF01806379.
7
Prospective evaluation of prognostic value of morphometry in patients with primary breast cancer.
J Clin Pathol. 1987 Mar;40(3):302-6. doi: 10.1136/jcp.40.3.302.
8
The predictive value of steroid hormone receptor analysis in breast, endometrial and ovarian cancer.
Med Oncol Tumor Pharmacother. 1986;3(3-4):197-210. doi: 10.1007/BF02934996.
9
Steroid hormone receptors and prognosis in breast cancer.
Breast Cancer Res Treat. 1988 Dec;12(3):267-73. doi: 10.1007/BF01811239.
10
The long term prognostic significance of oestrogen receptor analysis in early carcinoma of the breast.
Br J Cancer. 1991 Jul;64(1):99-101. doi: 10.1038/bjc.1991.249.
本文引用的文献
1
Quantitative estrogen receptor analyses: the response to endocrine and cytotoxic chemotherapy in human breast cancer and the disease-free interval.
Cancer. 1980 Dec 15;46(12 Suppl):2829-34. doi: 10.1002/1097-0142(19801215)46:12+<2829::aid-cncr2820461419>3.0.co;2-m.
2
The prognostic value of estrogen receptor determinations in patients with primary breast cancer: an update.
Cancer. 1980 Dec 15;46(12 Suppl):2794-6. doi: 10.1002/1097-0142(19801215)46:12+<2794::aid-cncr2820461410>3.0.co;2-n.
3
Relationship between primary breast tumor receptor status and patient survival.
Cancer. 1980 Dec 15;46(12 Suppl):2765-9. doi: 10.1002/1097-0142(19801215)46:12+<2765::aid-cncr2820461404>3.0.co;2-c.
4
Estrogen receptors and breast cancer: prognostic and therapeutic implications.
Surgery. 1980 Sep;88(3):386-93.
5
The relative importance of estrogen receptor analysis as a prognostic factor for recurrence or response to chemotherapy in women with breast cancer.
Cancer. 1980 Apr 15;45(8):1993-2000. doi: 10.1002/1097-0142(19800415)45:8<1993::aid-cncr2820450802>3.0.co;2-2.
6
Estrogen receptor protein in breast cancer as a predictor of recurrence.
Cancer. 1981 May 15;47(10):2364-7. doi: 10.1002/1097-0142(19810515)47:10<2364::aid-cncr2820471007>3.0.co;2-s.
7
Estrogen receptor level and other factors in early recurrence of breast cancer.
Int J Cancer. 1980 Oct 15;26(4):429-33. doi: 10.1002/ijc.2910260407.
8
The association of cytosol oestrogen and progesterone receptors with histological features of breast cancer and early recurrence of disease.
Br J Cancer. 1983 May;47(5):629-40. doi: 10.1038/bjc.1983.101.
9
Female sex steroid receptor status in primary and metastatic breast carcinoma and its relationship to serum steroid peptide hormone levels.
Int J Cancer. 1980 Jul 15;26(1):13-21. doi: 10.1002/ijc.2910260104.
10
Progesterone receptors as a prognostic factor in Stage II breast cancer.
N Engl J Med. 1983 Dec 1;309(22):1343-7. doi: 10.1056/nejm198312013092240.
Zotero 插件